A detailed history of Allworth Financial LP transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Allworth Financial LP holds 100 shares of AMRN stock, worth $53. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 100 -0.0%
Holding current value
$53
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 22, 2022

SELL
$2.85 - $3.73 $6,523 - $8,537
-2,289 Reduced 95.81%
100 $0
Q4 2021

Jan 21, 2022

BUY
$3.24 - $5.18 $7,416 - $11,857
2,289 Added 2289.0%
2,389 $8,000
Q4 2018

Feb 11, 2019

BUY
$12.41 - $22.98 $1,241 - $2,298
100 New
100 $1,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $214M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.